Combination Interventions for Anemia

Overseen By Sahar Sarfaraz

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: The University of Texas Health Science Center, Houston

Disqualifiers: Diabetes, Hypertension, Bipolar, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

1368 Participants Needed

Trial Summary

What is the purpose of this trial?

The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.

Research Team

Eric Thomas, MD, MPH

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for adults with new, significant anemia or reduced kidney function (eGFR <60 ml/min/1.73m2) seen at University of Texas Physicians clinics. It's not suitable for those who don't meet these specific blood and kidney health criteria.

Inclusion Criteria

I have new anemia or my kidney function is lower than normal.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Control

Clinics are in a control phase before the intervention is implemented

6-24 months

Intervention

Implementation of evidence-based interventions to improve diagnostic safety and efficiency

6-24 months

Follow-up

Participants are monitored for safety and effectiveness after intervention

1-6 months

Treatment Details

Interventions

• Consultation with a Specialist
• Evidence-Based Interventions

Trial Overview The study tests whether usual care combined with specialist consultations improves patient safety and efficiency in diagnosing primary care conditions like anemia and reduced kidney function.

Participant Groups

Group I: Step 4 (4 clinics) - 24 months control followed by 6 months of intervention Experimental Treatment 2 Interventions

Group II: Step 3 (3 clinics) - 18 months control followed by 12 months of intervention Experimental Treatment 2 Interventions

Group III: Step 2 (3 clinics) - 12 months control followed by 18 months of intervention Experimental Treatment 2 Interventions

Group IV: Step 1 (3 clinics) - 6 months control followed by 24 months of intervention Experimental Treatment 2 Interventions

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials

974

Recruited

361,000+